206 related articles for article (PubMed ID: 2439789)
1. Balanced pharmacokinetics and metabolism of bisoprolol.
Leopold G
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S16-20. PubMed ID: 2439789
[TBL] [Abstract][Full Text] [Related]
2. Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist.
Leopold G; Pabst J; Ungethüm W; Bühring KU
J Clin Pharmacol; 1986; 26(8):616-21. PubMed ID: 2878941
[TBL] [Abstract][Full Text] [Related]
3. High beta 1-selectivity and favourable pharmacokinetics as the outstanding properties of bisoprolol.
Haeusler G; Schliep HJ; Schelling P; Becker KH; Klockow M; Minck KO; Enenkel HJ; Schulze E; Bergmann R; Schmitges CJ
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S2-15. PubMed ID: 2439793
[TBL] [Abstract][Full Text] [Related]
4. The single dose pharmacokinetics of bisoprolol (10 mg) in renal insufficiency: the clinical significance of balanced clearance.
Payton CD; Fox JG; Pauleau NF; Boulton-Jones JM; Ioannides C; Johnston A; Thomas P
Eur Heart J; 1987 Dec; 8 Suppl M():15-22. PubMed ID: 2897297
[TBL] [Abstract][Full Text] [Related]
5. Interaction of bisoprolol with cimetidine and rifampicin.
Kirch W; Rose I; Klingmann I; Pabst J; Ohnhaus EE
Eur J Clin Pharmacol; 1986; 31(1):59-62. PubMed ID: 2877885
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease.
Kirch W; Rose I; Demers HG; Leopold G; Pabst J; Ohnhaus EE
Clin Pharmacokinet; 1987 Aug; 13(2):110-7. PubMed ID: 2887325
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and metabolism of bisoprolol-14C in three animal species and in humans.
Bühring KU; Sailer H; Faro HP; Leopold G; Pabst J; Garbe A
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S21-8. PubMed ID: 2439794
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance.
Borchard U
Clin Physiol Biochem; 1990; 8 Suppl 2():28-34. PubMed ID: 1982759
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics and metabolism of bevantolol.
Latts JR
Angiology; 1986 Mar; 37(3 Pt 2):221-5. PubMed ID: 2871781
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
Johnsson G; Regàrdh CG
Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.
Beddies G; Fox PR; Papich MD; Kanikanti VR; Krebber R; Keene BW
Am J Vet Res; 2008 Dec; 69(12):1659-63. PubMed ID: 19046015
[TBL] [Abstract][Full Text] [Related]
12. Absolute bioavailability study in the dog with Visacor, a new cardioselective beta blocking drug with intrinsic sympathomimetic activity.
McAinsh J; Smith RP; Ferguson RA
Eur J Drug Metab Pharmacokinet; 1984; 9(2):129-39. PubMed ID: 6146530
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective pharmacokinetics of bisoprolol after intravenous and oral administration in beagle dogs.
Horikiri Y; Suzuki T; Mizobe M
J Pharm Sci; 1997 May; 86(5):560-4. PubMed ID: 9145379
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of atenolol--a review.
Kirch W; Görg KG
Eur J Drug Metab Pharmacokinet; 1982; 7(2):81-91. PubMed ID: 6749509
[TBL] [Abstract][Full Text] [Related]
15. Consequences of renal insufficiency on the hepatic clearance of some drugs.
Balant LP; Dayer P; Fabre J
Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent.
Ishizaki T; Ohnishi A; Sasaki T; Kushida K; Horai Y; Chiba K; Suganuma T
Eur J Clin Pharmacol; 1983; 25(1):95-101. PubMed ID: 6137389
[TBL] [Abstract][Full Text] [Related]
17. Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assay.
Wellstein A; Palm D; Belz GG; Leopold G; Bühring KU; Pabst J
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S41-5. PubMed ID: 2439797
[TBL] [Abstract][Full Text] [Related]
18. Single oral dose pharmacokinetics of bisoprolol 10 mg in liver disease.
Hayes PC; Jenkins D; Vavianos P; Dagap K; Johnston A; Ioannides C; Thomas P; Williams R
Eur Heart J; 1987 Dec; 8 Suppl M():23-9. PubMed ID: 2897298
[TBL] [Abstract][Full Text] [Related]
19. [Clearance concept applied to pharmacokinetics: 2. Experience with tolamolol (beta-blocking agent) in renal insufficiency (author's transl)].
Balant L; Gorgia A; Marmy A; Tschopp JM
Nephrologie; 1980; 1(4):177-82. PubMed ID: 6895408
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of prazosin.
Jaillon P
Clin Pharmacokinet; 1980; 5(4):365-76. PubMed ID: 6994981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
